Search

Your search keyword '"Moncusí-Moix, Anna"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Moncusí-Moix, Anna" Remove constraint Author: "Moncusí-Moix, Anna"
135 results on '"Moncusí-Moix, Anna"'

Search Results

3. Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity

5. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

6. Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection

7. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study

8. MicroRNA‐guided drug discovery for mitigating persistent pulmonary complications in critical COVID‐19 survivors: A longitudinal pilot study

9. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients

11. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events

12. A blood-based microRNA signature for the early prediction of the respiratory sequelae in critical COVID-19

13. A plasma microRNA panel strengthens the early prediction of ICU mortality: A multicenter COVID-19 study

15. Adherence to CPAP treatment is associated with a decrease in the incidence of cardiovascular events: an individual participant data meta-analysis

16. Persistence of lung dysfunction in post-acute COVID-19: a microRNA approach

17. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

18. REVISADO GATEKEEPER’s strategy for the multinational large-scale piloting of an eHealth platform: tutorial on how to identify relevant settings and use cases

19. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

20. Additional file 7 of Breathing cessation events that compose the apnea–hypopnea index are distinctively associated with the adverse outcomes in Alzheimer’s disease

21. Additional file 2 of A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

22. Additional file 5 of Breathing cessation events that compose the apnea–hypopnea index are distinctively associated with the adverse outcomes in Alzheimer’s disease

23. Additional file 1 of A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

24. Additional file 6 of Breathing cessation events that compose the apnea–hypopnea index are distinctively associated with the adverse outcomes in Alzheimer’s disease

25. Sleep and circadian health 6 months after critical COVID ‐19 disease

26. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

27. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

28. Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS

29. Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection

30. One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill Patients

31. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

32. Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill Patients

33. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

34. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study

35. Three to Six Months Evolution of Pulmonary Function and Radiological Features in Critical COVID-19 Patients: A Prospective Cohort

36. Sleep and Circadian Health of Critical COVID-19 Survivors 3 Months After Hospital Discharge

37. Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill Patients

38. Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS

39. Plasma profiling reveals a blood-based metabolic fingerprint of obstructive sleep apnea

40. Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort

41. Pulmonary Function and Radiological Features in Survivors of Critical Covid-19: A 3-Month Prospective Cohort

42. Clinical management and outcome differences between first and second waves among COVID-19 hospitalized patients: A regional prospective observational cohort

43. Management and Treatment of Patients With Obstructive Sleep Apnea Using an Intelligent Monitoring System Based on Machine Learning Aiming to Improve Continuous Positive Airway Pressure Treatment Compliance: Randomized Controlled Trial

44. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients

45. Potential translation of plasma microRNA signatures in the risk stratification of COVID-19 patients admitted to the ICU

46. Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19

47. Late Breaking Abstract - MicroRNA profiling informs on the pulmonary sequelae of COVID-19-induced ARDS

48. Late Breaking Abstract - MicroRNA signatures in critically ill COVID-19 patients: a bronchial aspirate study

49. Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer’s Disease

50. Clinical Consequences of COVID-19 Lockdown in Patients With COPD

Catalog

Books, media, physical & digital resources